BC Week In Review | Dec 21, 2018
Company News

Astellas exercises option to acquire Potenza

Astellas Pharma Inc. (Tokyo:4503) exercised an exclusive option under an April 2015 deal and acquired Potenza Therapeutics Inc. (Cambridge, Mass.) (see "Potenza Therapeutics, Astellas Deal" ). Potenza received $164.6 million up front and is eligible...
Items per page:
1 - 1 of 1